Observational Study of the Effects Intravenous Bortezomib Has on Osteoblast (Cell That is Responsible for Bone Formation) Activity in Multiple Myeloma Patients.
Clinical trial NCT01026701 · COMPLETED
Trial details
- NCT number
- NCT01026701
- Sponsor
- Janssen Korea, Ltd., Korea
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2008-03-01
- Primary completion
- 2009-11-01
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.